A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Randomised, Open-label, Parallel-group, Multi-centre Trial (FE 999905 CS07) in Which the Efficacy and Safety of 12 Months' Treatment With One Daily Dose of ZOMACTON Were Compared to One Daily Dose of GENOTROPIN
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Pharmacodynamics
- Sponsors Ferring Pharmaceuticals
Most Recent Events
- 04 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 05 Jul 2014 New source identified and integrated (European Clinical Trials Database record: EudraCT2014-000627-24HU)
- 01 Jul 2014 New trial record